EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Deubiquitination of RIPK2 by OTUB2 augments NOD2 signalling and protective effects in intestinal inflammation

Xue Du, Jun Xu, Fuqi Mei, Jiangyun Shen, Bincheng Zhou, Zhenhu Zhu, Zhongding Li, Xian Su, Jianmin Li, Dirk Schlüter, Jing Ruan, Xu Wang iD

Clinical and Translational Medicine · 2024

DOI: 10.1002/ctm2.70038 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Translational Medicine, 2024. Verfasst von Xue Du und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, China. Hauptthemen laut MEDLINE: Receptor-Interacting Protein Serine-Threonine Kinase 2, Nod2 Signaling Adaptor Protein, Signal Transduction. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Zhejiang Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Inflammatory bowel disease (IBD) is a chronic inflammatory disorder of the gastrointestinal tract, but the molecular mechanisms underlying IBD are incompletely understood. In this study, we explored the role and regulating mechanism of otubain 2 (OTUB2), a deubiquitinating enzyme, in IBD.

Methods

To study the function of OTUB2 in IBD, we generated Otub2 –/– mice and treated them with dextran sulfate sodium (DSS) to induce experimental colitis. Bone marrow transplantation was performed to identify the cell populations that were affected by OTUB2 in colitis. The molecular mechanism of OTUB2 in signal transduction was studied by various biochemical methods.

Results

OTUB2 was highly expressed in colon‐infiltrating macrophages in both humans with IBD and mice with DSS‐induced experimental colitis. Colitis was significantly aggravated in Otub2 –/– mice and bone marrow chimeric mice receiving Otub2 –/– bone marrow. OTUB2‐deficiency impaired the production of cytokines and chemokines in macrophages in response to the NOD2 agonist muramyl dipeptide (MDP). Upon MDP stimulation, OTUB2 promoted NOD2 signaling by stabilizing RIPK2. Mechanistically, OTUB2 inhibited the proteasomal degradation of RIPK2 by removing K48‐linked polyubiquitination on RIPK2, which was mediated by the active C51 residue in OTUB2. In mice, OTUB2 ablation abolished the protective effects of MDP administration in colitis.

Conclusion

This study identified OTUB2 as a novel regulator of intestinal inflammation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptor-Interacting Protein Serine-Threonine Kinase 2Nod2 Signaling Adaptor ProteinSignal TransductionAnimalsMiceHumansColitisDisease Models, AnimalMice, KnockoutMice, Inbred C57BLInflammationUbiquitination

Stichwörter der Autor:innen

OTUB2RIPK2inflammatory bowel diseasesignal transductionubiquitination

Substanzen

Receptor-Interacting Protein Serine-Threonine Kinase 2Nod2 Signaling Adaptor ProteinRipk2 protein, mouseNod2 protein, mouse

Autor:innen und Institutionen

  • School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, China.
  • Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health), Wenzhou, China.
  • Department of Pathology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • Hannover Medical School, Institute of Medical Microbiology and Hospital Epidemiology, Hannover, Germany.

ORCID-Profile: Xu Wang

Förderung

  • Natural Science Foundation of Zhejiang Province
  • National Natural Science Foundation of China

Zitieren

APA

Du, X., Xu, J., Mei, F., Shen, J., Zhou, B., Zhu, Z., Li, Z., Su, X., Li, J., Schlüter, D., Ruan, J., & Wang, X. (2024). Deubiquitination of RIPK2 by OTUB2 augments NOD2 signalling and protective effects in intestinal inflammation. Clinical and Translational Medicine. https://doi.org/10.1002/ctm2.70038

Vancouver

Du X, Xu J, Mei F, Shen J, Zhou B, Zhu Z, et al. Deubiquitination of RIPK2 by OTUB2 augments NOD2 signalling and protective effects in intestinal inflammation. Clinical and Translational Medicine. 2024. doi:10.1002/ctm2.70038

BibTeX
@article{Du2024,
  author = {Du, Xue and Xu, Jun and Mei, Fuqi and Shen, Jiangyun and Zhou, Bincheng and Zhu, Zhenhu and Li, Zhongding and Su, Xian and Li, Jianmin and Schlüter, Dirk and Ruan, Jing and Wang, Xu},
  title = {Deubiquitination of RIPK2 by OTUB2 augments NOD2 signalling and protective effects in intestinal inflammation},
  journal = {Clinical and Translational Medicine},
  year = {2024},
  doi = {10.1002/ctm2.70038}
}
Kostenlos starten →